{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:58:03Z","timestamp":1787162283851,"version":"build-2736575974"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s11883-022-01047-1","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T02:09:44Z","timestamp":1656468584000},"page":"721-730","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Transgender Cardiovascular Health: Practical Management for the Clinician"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4432-5926","authenticated-orcid":false,"given":"Caroline","family":"Ong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadiya","family":"Thermidor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwen","family":"Eid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Gianos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"issue":"2","key":"1047_CR1","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10865-019-00102-8","volume":"43","author":"BA Caceres","year":"2020","unstructured":"Caceres BA, Jackman KB, Edmondson D, Bockting WO. Assessing gender identity differences in cardiovascular disease in US adults: an analysis of data from the 2014\u20132017 BRFSS. J Behav Med. 2020;43(2):329\u201338. https:\/\/doi.org\/10.1007\/s10865-019-00102-8.","journal-title":"J Behav Med"},{"issue":"10042","key":"1047_CR2","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/S0140-6736(16)00683-8","volume":"388","author":"S Winter","year":"2016","unstructured":"Winter S, Diamond M, Green J, Karasic D, Reed T, Whittle S, et al. Transgender people: health at the margins of society. Lancet. 2016;388(10042):390\u2013400. https:\/\/doi.org\/10.1016\/S0140-6736(16)00683-8.","journal-title":"Lancet"},{"key":"1047_CR3","unstructured":"Grant JM, Mottet L, Tanis JE, Herman J, Harrison J, Keisling M, et al. National transgender discrimination survey report on health and health care: findings of a study by the National Center for Transgender Equality and the National Gay and Lesbian Task Force. National Center for Transgender Equality; 2010.\u00a0\u00a0https:\/\/cancer-network.org\/wp-content\/uploads\/2017\/02\/National_Transgender_Discrimination_Survey_Report_on_health_and_health_care.pdf. Accessed 1 June 2022.\u00a0"},{"key":"1047_CR4","unstructured":"\u2022 Coleman E, Bockting W, Botzer M, Cohen-Kettenis P, Decuypere G, Feldman J, et al. Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7. Int J Transgenderism. 2011;13(165).\u00a0https:\/\/www.wpath.org\/publications\/soc. Accessed 1 June 2022. This paper provides comprehensive clinical guidelines and expert consensus for the safe and effective care of transgender and gender diverse persons. An updated version 8 is expected to be published in 2022."},{"key":"1047_CR5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-01658","author":"WC Hembree","year":"2017","unstructured":"Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH, et al. Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2017. https:\/\/doi.org\/10.1210\/jc.2017-01658.","journal-title":"J Clin Endocrinol Metab"},{"key":"1047_CR6","unstructured":"Deutsch MB. Guidelines for the primary and gender-affirming care of transgender and gender nonbinary people introduction to the guidelines. San Francisco, CA. 2016.\u00a0https:\/\/transcare.ucsf.edu\/sites\/transcare.ucsf.edu\/files\/Transgender-PGACG-6-17-16.pdf. Accessed 1 June 2022."},{"issue":"1","key":"1047_CR7","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1089\/trgh.2016.0019","volume":"1","author":"EK Edmiston","year":"2016","unstructured":"Edmiston EK, Donald CA, Sattler AR, Peebles JK, Ehrenfeld JM, Eckstrand KL. Opportunities and gaps in primary care preventative health services for transgender patients: a systemic review. Transgend Health. 2016;1(1):216\u201330. https:\/\/doi.org\/10.1089\/trgh.2016.0019.","journal-title":"Transgend Health"},{"key":"1047_CR8","doi-asserted-by":"publisher","unstructured":"\u2022 Caceres BA, Streed CG, Jr., Corliss HL, Lloyd-Jones DM, Matthews PA, Mukherjee M, et al. Assessing and addressing cardiovascular health in LGBTQ adults: a scientific statement from the American Heart Association. Circulation. 2020;142(19):e321-e32. https:\/\/doi.org\/10.1161\/CIR.0000000000000914. This scientific statement presents a comprehensive review of available evidence and conceptual models on the cardiovascular health of transgender, gender diverse, and sexual minority adults.","DOI":"10.1161\/CIR.0000000000000914"},{"key":"1047_CR9","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s12170-013-0365-2","volume":"8","author":"T Lewis","year":"2014","unstructured":"Lewis T, Williams D, Tamene M, Clark C. Self-reported experiences of discrimination and cardiovascular disease. Curr Cardiovasc Risk Rep. 2014;8:365.","journal-title":"Curr Cardiovasc Risk Rep"},{"issue":"6","key":"1047_CR10","doi-asserted-by":"publisher","first-page":"e0217623","DOI":"10.1371\/journal.pone.0217623","volume":"14","author":"GA Panza","year":"2019","unstructured":"Panza GA, Puhl RM, Taylor BA, Zaleski AL, Livingston J, Pescatello LS. Links between discrimination and cardiovascular health among socially stigmatized groups: a systematic review. PLoS ONE. 2019;14(6):e0217623.","journal-title":"PLoS ONE"},{"key":"1047_CR11","unstructured":"Project. MA: Equality maps: state nondiscrimination laws. https:\/\/www.lgbtmap.org\/equality-maps\/non_discrimination_laws\/public-accommodations Accessed 02\/15\/2022."},{"issue":"Suppl 2","key":"1047_CR12","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1111\/1475-6773.13229","volume":"54","author":"LS Casey","year":"2019","unstructured":"Casey LS, Reisner SL, Findling MG, Blendon RJ, Benson JM, Sayde JM, et al. Discrimination in the United States: experiences of lesbian, gay, bisexual, transgender, and queer Americans. Health Serv Res. 2019;54(Suppl 2):1454\u201366. https:\/\/doi.org\/10.1111\/1475-6773.13229.","journal-title":"Health Serv Res"},{"issue":"2","key":"1047_CR13","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1215\/00703370-8976151","volume":"58","author":"D Lagos","year":"2021","unstructured":"Lagos D, Compton D. Evaluating the use of a two-step gender identity measure in the 2018 general social survey. Demography. 2021;58(2):763\u201371. https:\/\/doi.org\/10.1215\/00703370-8976151.","journal-title":"Demography"},{"issue":"3","key":"1047_CR14","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s13178-016-0220-6","volume":"13","author":"E Lombardi","year":"2016","unstructured":"Lombardi E, Banik S. The utility of the two-step gender measure within trans and cis populations. Sex Res Social Policy. 2016;13(3):288\u201396. https:\/\/doi.org\/10.1007\/s13178-016-0220-6.","journal-title":"Sex Res Social Policy"},{"issue":"4","key":"1047_CR15","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1530\/EJE-10-1038","volume":"164","author":"H Asscheman","year":"2011","unstructured":"Asscheman H, Giltay EJ, Megens JAJ, De Ronde W, Van Trotsenburg MAA, Gooren LJG. A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones. Eur J Endocrinol. 2011;164(4):635\u201342. https:\/\/doi.org\/10.1530\/EJE-10-1038.","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"1047_CR16","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1046\/j.1365-2265.1997.2601068.x","volume":"47","author":"PJM Van Kesteren","year":"1997","unstructured":"Van Kesteren PJM, Asscheman H, Megens JAJ, Gooren LJG. Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clin Endocrinol. 1997;47(3):337\u201343. https:\/\/doi.org\/10.1046\/j.1365-2265.1997.2601068.x.","journal-title":"Clin Endocrinol"},{"issue":"21","key":"1047_CR17","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1093\/EURHEARTJ\/EHN408","volume":"29","author":"E L\u00f8kkegaard","year":"2008","unstructured":"L\u00f8kkegaard E, Andreasen AH, Jacobsen RK, Nielsen LH, Agger C, Lidegaard \u00d8. Hormone therapy and risk of myocardial infarction: a national register study. Eur Heart J. 2008;29(21):2660\u20138. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHN408.","journal-title":"Eur Heart J"},{"issue":"7763","key":"1047_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1136\/BMJ.C2519","volume":"340","author":"C Renoux","year":"2010","unstructured":"Renoux C, Dell\u2019Aniello S, Garbe E, Suissa S. Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study. BMJ. 2010;340(7763):83. https:\/\/doi.org\/10.1136\/BMJ.C2519.","journal-title":"BMJ"},{"issue":"9382","key":"1047_CR19","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S0140-6736(03)14066-4","volume":"362","author":"PY Scarabin","year":"2003","unstructured":"Scarabin PY, Oger E, Plu-Bureau G. Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk. Lancet. 2003;362(9382):428\u201332. https:\/\/doi.org\/10.1016\/S0140-6736(03)14066-4.","journal-title":"Lancet"},{"issue":"4","key":"1047_CR20","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1160\/TH06-10-0567","volume":"97","author":"JF Brosnan","year":"2007","unstructured":"Brosnan JF, Sheppard BL, Norris LA. Haemostatic activation in post-menopausal women taking low-dose hormone therapy: less effect with transdermal administration? Thromb Haemost. 2007;97(4):558\u201365.","journal-title":"Thromb Haemost"},{"issue":"1","key":"1047_CR21","first-page":"124","volume":"90","author":"K Lacut","year":"2003","unstructured":"Lacut K, Oger E, Le Gal G, Blouch MT, Abgrall JF, Kerlan V, et al. Differential effects of oral and transdermal postmenopausal estrogen replacement therapies on C-reactive protein. Thromb Haemost. 2003;90(1):124\u201331.","journal-title":"Thromb Haemost"},{"issue":"5","key":"1047_CR22","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1210\/jc.2007-2193","volume":"93","author":"JL Shifren","year":"2008","unstructured":"Shifren JL, Rifai N, Desindes S, McIlwain M, Doros G, Mazer NA. A comparison of the short-term effects of oral conjugated equine estrogens versus transdermal estradiol on C-reactive protein, other serum markers of inflammation, and other hepatic proteins in naturally menopausal women. J Clin Endocrinol Metab. 2008;93(5):1702\u201310. https:\/\/doi.org\/10.1210\/jc.2007-2193.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1047_CR23","doi-asserted-by":"publisher","first-page":"810","DOI":"10.5551\/jat.33175","volume":"23","author":"S Nii","year":"2016","unstructured":"Nii S, Shinohara K, Matsushita H, Noguchi Y, Watanabe K, Wakatsuki A. Hepatic effects of estrogen on plasma distribution of small dense low-density lipoprotein and free radical production in postmenopausal women. J Atheroscler Thromb. 2016;23(7):810\u20138. https:\/\/doi.org\/10.5551\/jat.33175.","journal-title":"J Atheroscler Thromb"},{"issue":"1","key":"1047_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1210\/JC.2007-1809","volume":"93","author":"LJ Gooren","year":"2008","unstructured":"Gooren LJ, Giltay EJ, Bunck MC. Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience. J Clin Endocrinol Metab. 2008;93(1):19\u201325. https:\/\/doi.org\/10.1210\/JC.2007-1809.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1047_CR25","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/BF01579291","volume":"18","author":"JC Prior","year":"1989","unstructured":"Prior JC, Vigna YM, Watson D. Spironolactone with physiological female steroids for presurgical therapy of male-to-female transsexualism. Arch Sex Behav. 1989;18(1):49\u201357. https:\/\/doi.org\/10.1007\/BF01579291.","journal-title":"Arch Sex Behav"},{"key":"1047_CR26","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1023\/A:1026563806480","volume":"4","author":"KA Oriel","year":"2000","unstructured":"Oriel KA. Clinical update: medical care of transsexual patients. J Gay Lesbian Med Assoc. 2000;4:185\u201394.","journal-title":"J Gay Lesbian Med Assoc"},{"issue":"4","key":"1047_CR27","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1210\/jc.2018-01777","volume":"104","author":"JC Prior","year":"2019","unstructured":"Prior JC. Progesterone is important for transgender women\u2019s therapy\u2014applying evidence for the benefits of progesterone in ciswomen. J Clin Endocrinol Metab. 2019;104(4):1181\u20136. https:\/\/doi.org\/10.1210\/jc.2018-01777.","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"1047_CR28","first-page":"146","volume":"17","author":"JC Prior","year":"2017","unstructured":"Prior JC, Seifert-Klauss VR, Giustini D, Adachi JD, Kalyan S, Goshtasebi A. Estrogen-progestin therapy causes a greater increase in spinal bone mineral density than estrogen therapy\u2014a systematic review and meta-analysis of controlled trials with direct randomization. J Musculoskelet Neuronal Interact. 2017;17(3):146\u201354.","journal-title":"J Musculoskelet Neuronal Interact"},{"issue":"13","key":"1047_CR29","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1001\/jama.2013.278040","volume":"310","author":"JAE Manson","year":"2013","unstructured":"Manson JAE, Chlebowski RT, Stefanick ML, Aragaki AK, Rossouw JE, Prentice RL, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the women\u2019s health initiative randomized trials. JAMA. 2013;310(13):1353\u201368. https:\/\/doi.org\/10.1001\/jama.2013.278040.","journal-title":"JAMA"},{"issue":"7","key":"1047_CR30","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.106.642280","volume":"115","author":"M Canonico","year":"2007","unstructured":"Canonico M, Oger E, Plu-Bureau G, Conard J, Meyer G, L\u00e9vesque H, et al. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Circulation. 2007;115(7):840\u20135. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.642280.","journal-title":"Circulation"},{"issue":"2","key":"1047_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1210\/er.2012-1008","volume":"34","author":"FZ Stanczyk","year":"2013","unstructured":"Stanczyk FZ, Hapgood JP, Winer S, Mishell DR Jr. Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects. Endocr Rev. 2013;34(2):171\u2013208. https:\/\/doi.org\/10.1210\/er.2012-1008.","journal-title":"Endocr Rev."},{"issue":"8","key":"1047_CR32","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1161\/CIRCULATIONAHA.107.760405","volume":"118","author":"B Olshansky","year":"2008","unstructured":"Olshansky B, Sabbah HN, Hauptman PJ, Colucci WS. Parasympathetic nervous system and heart failure: pathophysiology and potential implications for therapy. Circulation. 2008;118(8):863\u201371. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.760405.","journal-title":"Circulation"},{"key":"1047_CR33","doi-asserted-by":"publisher","unstructured":"Nagai M, Forster CY, Dote K. Sex hormone-specific neuroanatomy of Takotsubo syndrome: is the insular cortex a moderator? Biomolecules. 2022;12(1). https:\/\/doi.org\/10.3390\/biom12010110.","DOI":"10.3390\/biom12010110"},{"issue":"3","key":"1047_CR34","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/s0008-6363(01)00508-9","volume":"53","author":"AM Dart","year":"2002","unstructured":"Dart AM, Du XJ, Kingwell BA. Gender, sex hormones and autonomic nervous control of the cardiovascular system. Cardiovasc Res. 2002;53(3):678\u201387. https:\/\/doi.org\/10.1016\/s0008-6363(01)00508-9.","journal-title":"Cardiovasc Res"},{"issue":"4","key":"1047_CR35","doi-asserted-by":"publisher","first-page":"e005597","DOI":"10.1161\/CIRCOUTCOMES.119.005597","volume":"12","author":"T Alzahrani","year":"2019","unstructured":"Alzahrani T, Nguyen T, Ryan A, Dwairy A, McCaffrey J, Yunus R, et al. Cardiovascular disease risk factors and myocardial infarction in the transgender population. Circ Cardiovasc Qual Outcomes. 2019;12(4):e005597. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.119.005597.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"11","key":"1047_CR36","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1161\/CIRCULATIONAHA.118.038584","volume":"139","author":"NM Nota","year":"2019","unstructured":"Nota NM, Wiepjes CM, de Blok CJM, Gooren LJG, Kreukels BPC, den Heijer M. Occurrence of acute cardiovascular events in transgender individuals receiving hormone therapy. Circulation. 2019;139(11):1461\u20132. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.038584.","journal-title":"Circulation"},{"issue":"4","key":"1047_CR37","doi-asserted-by":"publisher","first-page":"205","DOI":"10.7326\/M17-2785","volume":"169","author":"D Getahun","year":"2018","unstructured":"Getahun D, Nash R, Flanders WD, Baird TC, Becerra-Culqui TA, Cromwell L, et al. Cross-sex hormones and acute cardiovascular events in transgender persons: a cohort study. Ann Intern Med. 2018;169(4):205\u201313. https:\/\/doi.org\/10.7326\/M17-2785.","journal-title":"Ann Intern Med"},{"issue":"1","key":"1047_CR38","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13293-020-00323-6","volume":"11","author":"T Stone","year":"2020","unstructured":"Stone T, Stachenfeld NS. Pathophysiological effects of androgens on the female vascular system. Biol Sex Differ. 2020;11(1):45. https:\/\/doi.org\/10.1186\/s13293-020-00323-6.","journal-title":"Biol Sex Differ"},{"issue":"2","key":"1047_CR39","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/cen.14132","volume":"92","author":"BI Gulanski","year":"2020","unstructured":"Gulanski BI, Flannery CA, Peter PR, Leone CA, Stachenfeld NS. Compromised endothelial function in transgender men taking testosterone. Clin Endocrinol (Oxf). 2020;92(2):138\u201344. https:\/\/doi.org\/10.1111\/cen.14132.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"1047_CR40","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1210\/jc.2018-02138","volume":"104","author":"DM van Velzen","year":"2019","unstructured":"van Velzen DM, Paldino A, Klaver M, Nota NM, Defreyne J, Hovingh GK, et al. Cardiometabolic effects of testosterone in transmen and estrogen plus cyproterone acetate in transwomen. J Clin Endocrinol Metab. 2019;104(6):1937\u201347. https:\/\/doi.org\/10.1210\/jc.2018-02138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1047_CR41","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1161\/HYPERTENSIONAHA.120.16839","volume":"77","author":"K Banks","year":"2021","unstructured":"Banks K, Kyinn M, Leemaqz SY, Sarkodie E, Goldstein D, Irwig MS. Blood pressure effects of gender-affirming hormone therapy in transgender and gender-diverse adults. Hypertension. 2021;77(6):2066\u201374. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.120.16839.","journal-title":"Hypertension"},{"issue":"4","key":"1047_CR42","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/J.JPSYCHORES.2015.02.001","volume":"78","author":"M Colizzi","year":"2015","unstructured":"Colizzi M, Costa R, Scaramuzzi F, Palumbo C, Tyropani M, Pace V, et al. Concomitant psychiatric problems and hormonal treatment induced metabolic syndrome in gender dysphoria individuals: a 2 year follow-up study. J Psychosom Res. 2015;78(4):399\u2013406. https:\/\/doi.org\/10.1016\/J.JPSYCHORES.2015.02.001.","journal-title":"J Psychosom Res"},{"issue":"8","key":"1047_CR43","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1111\/jsm.12571","volume":"11","author":"K Wierckx","year":"2014","unstructured":"Wierckx K, Van Caenegem E, Schreiner T, Haraldsen I, Fisher AD, Toye K, et al. Cross-sex hormone therapy in transpersons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence. J Sex Med. 2014;11(8):1999\u20132011. https:\/\/doi.org\/10.1111\/jsm.12571.","journal-title":"J Sex Med"},{"issue":"11","key":"1047_CR44","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.1210\/jc.2017-01643","volume":"102","author":"S Maraka","year":"2017","unstructured":"Maraka S, Singh Ospina N, Rodriguez-Gutierrez R, Davidge-Pitts CJ, Nippoldt TB, Prokop LJ, et al. Sex steroids and cardiovascular outcomes in transgender individuals: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2017;102(11):3914\u201323.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1047_CR45","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1373\/clinchem.2018.292730","volume":"65","author":"JA SoRelle","year":"2019","unstructured":"SoRelle JA, Jiao R, Gao E, Veazey J, Frame I, Quinn AM, et al. Impact of hormone therapy on laboratory values in transgender patients. Clin Chem. 2019;65(1):170\u20139. https:\/\/doi.org\/10.1373\/clinchem.2018.292730.","journal-title":"Clin Chem"},{"issue":"1","key":"1047_CR46","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/jalm\/jfaa192","volume":"6","author":"AN Allen","year":"2021","unstructured":"Allen AN, Jiao R, Day P, Pagels P, Gimpel N, SoRelle JA. Dynamic impact of hormone therapy on laboratory values in transgender patients over time. J Appl Lab Med. 2021;6(1):27\u201340. https:\/\/doi.org\/10.1093\/jalm\/jfaa192.","journal-title":"J Appl Lab Med"},{"issue":"2","key":"1047_CR47","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.amjmed.2013.10.009","volume":"127","author":"TK Roberts","year":"2014","unstructured":"Roberts TK, Kraft CS, French D, Ji W, Wu AH, Tangpricha V, et al. Interpreting laboratory results in transgender patients on hormone therapy. Am J Med. 2014;127(2):159\u201362. https:\/\/doi.org\/10.1016\/j.amjmed.2013.10.009.","journal-title":"Am J Med"},{"issue":"3","key":"1047_CR48","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1097\/AOG.0000000000000692","volume":"125","author":"MB Deutsch","year":"2015","unstructured":"Deutsch MB, Bhakri V, Kubicek K. Effects of cross-sex hormone treatment on transgender women and men. Obstet Gynecol. 2015;125(3):605\u201310. https:\/\/doi.org\/10.1097\/AOG.0000000000000692.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"1047_CR49","doi-asserted-by":"publisher","first-page":"383","DOI":"10.4158\/EP15950.OR","volume":"22","author":"JD Fernandez","year":"2016","unstructured":"Fernandez JD, Tannock LR. Metabolic effects of hormone therapy in transgender patients. Endocr Pract. 2016;22(4):383\u20138. https:\/\/doi.org\/10.4158\/EP15950.OR.","journal-title":"Endocr Pract"},{"issue":"3","key":"1047_CR50","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1753-0407.2010.00085.x","volume":"2","author":"TH Jones","year":"2010","unstructured":"Jones TH. Effects of testosterone on type 2 diabetes and components of the metabolic syndrome. J Diabetes. 2010;2(3):146\u201356. https:\/\/doi.org\/10.1111\/j.1753-0407.2010.00085.x.","journal-title":"J Diabetes"},{"issue":"2","key":"1047_CR51","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1210\/jc.2017-01559","volume":"103","author":"MK Auer","year":"2018","unstructured":"Auer MK, Ebert T, Pietzner M, Defreyne J, Fuss J, Stalla GK, et al. Effects of sex hormone treatment on the metabolic syndrome in transgender individuals: focus on metabolic cytokines. J Clin Endocrinol Metab. 2018;103(2):790\u2013802. https:\/\/doi.org\/10.1210\/jc.2017-01559.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1047_CR52","doi-asserted-by":"publisher","first-page":"411","DOI":"10.2337\/dc19-1061","volume":"43","author":"S Shadid","year":"2020","unstructured":"Shadid S, Abosi-Appeadu K, De Maertelaere AS, Defreyne J, Veldeman L, Holst JJ, et al. Effects of gender-affirming hormone therapy on insulin sensitivity and incretin responses in transgender people. Diabetes Care. 2020;43(2):411\u20137. https:\/\/doi.org\/10.2337\/dc19-1061.","journal-title":"Diabetes Care"},{"key":"1047_CR53","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab832","author":"N Islam","year":"2021","unstructured":"Islam N, Nash R, Zhang Q, Panagiotakopoulos L, Daley T, Bhasin S, et al. Is there a link between hormone use and diabetes incidence in transgender people? Data from the STRONG cohort. J Clin Endocrinol Metab. 2021. https:\/\/doi.org\/10.1210\/clinem\/dgab832.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1047_CR54","doi-asserted-by":"publisher","first-page":"256","DOI":"10.7326\/M17-0577","volume":"167","author":"CG Streed Jr","year":"2017","unstructured":"Streed CG Jr, Harfouch O, Marvel F, Blumenthal RS, Martin SS, Mukherjee M. Cardiovascular disease among transgender adults receiving hormone therapy: a narrative review. Ann Intern Med. 2017;167(4):256\u201367. https:\/\/doi.org\/10.7326\/M17-0577.","journal-title":"Ann Intern Med"},{"key":"1047_CR55","unstructured":"James S, Herman J, Rankin S, Keisling M, Mottet L, Ma A. The report of the 2015 US transgender survey. 2016.\u00a0https:\/\/transequality.org\/sites\/default\/files\/docs\/usts\/USTS-Full-Report-Dec17.pdf. Accessed 1 June 2022."},{"issue":"6","key":"1047_CR56","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1089\/lgbt.2016.0208","volume":"4","author":"CN Dragon","year":"2017","unstructured":"Dragon CN, Guerino P, Ewald E, Laffan AM. Transgender Medicare beneficiaries and chronic conditions: exploring fee-for-service claims data. LGBT Health. 2017;4(6):404\u201311. https:\/\/doi.org\/10.1089\/lgbt.2016.0208.","journal-title":"LGBT Health"},{"issue":"3","key":"1047_CR57","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1093\/geront\/gnt021","volume":"54","author":"KI Fredriksen-Goldsen","year":"2014","unstructured":"Fredriksen-Goldsen KI, Cook-Daniels L, Kim HJ, Erosheva EA, Emlet CA, Hoy-Ellis CP, et al. Physical and mental health of transgender older adults: an at-risk and underserved population. Gerontologist. 2014;54(3):488\u2013500. https:\/\/doi.org\/10.1093\/geront\/gnt021.","journal-title":"Gerontologist"},{"key":"1047_CR58","doi-asserted-by":"publisher","unstructured":"Wilson OWA, Jones BA, Bopp M. College student aerobic and muscle-strengthening activity: disparities between cis-gender and transgender students in the United States. J Am CollHealth. 2021:1\u20136. https:\/\/doi.org\/10.1080\/07448481.2021.1895808.","DOI":"10.1080\/07448481.2021.1895808"},{"issue":"2","key":"1047_CR59","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/15532739.2017.1293581","volume":"18","author":"BA Jones","year":"2017","unstructured":"Jones BA, Arcelus J, Bouman WP, Haycraft E. Barriers and facilitators of physical activity and sport participation among young transgender adults who are medically transitioning. Int J Transgenderism. 2017;18(2):227\u201338. https:\/\/doi.org\/10.1080\/15532739.2017.1293581.","journal-title":"Int J Transgenderism"},{"issue":"4","key":"1047_CR60","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.amepre.2020.03.027","volume":"59","author":"L Kcomt","year":"2020","unstructured":"Kcomt L, Evans-Polce RJ, Veliz PT, Boyd CJ, McCabe SE. Use of cigarettes and e-cigarettes\/vaping among transgender people: results from the 2015 US transgender survey. Am J Prev Med. 2020;59(4):538\u201347.","journal-title":"Am J Prev Med"},{"key":"1047_CR61","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.drugpo.2019.07.024","volume":"73","author":"S Azagba","year":"2019","unstructured":"Azagba S, Latham K, Shan L. Cigarette, smokeless tobacco, and alcohol use among transgender adults in the United States. Int J Drug Policy. 2019;73:163\u20139.","journal-title":"Int J Drug Policy"},{"issue":"2","key":"1047_CR62","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2105\/AJPH.2017.304205","volume":"108","author":"JD Spivey","year":"2018","unstructured":"Spivey JD, Lee JG, Smallwood SW. Tobacco policies and alcohol sponsorship at lesbian, gay, bisexual, and transgender pride festivals: time for intervention. Am J Public Health. 2018;108(2):187.","journal-title":"Am J Public Health"},{"issue":"7","key":"1047_CR63","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1089\/lgbt.2018.0103","volume":"5","author":"JD Kidd","year":"2018","unstructured":"Kidd JD, Dolezal C, Bockting WO. The relationship between tobacco use and legal document gender-marker change, hormone use, and gender-affirming surgery in a United States sample of trans-feminine and trans-masculine individuals: implications for cardiovascular health. LGBT Health. 2018;5(7):401\u201311.","journal-title":"LGBT Health"},{"issue":"3","key":"1047_CR64","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/ntr\/ntab152","volume":"24","author":"JK Felner","year":"2021","unstructured":"Felner JK, Andrzejewski J, Strong D, Kieu T, Ravindran M, Corliss HL. Vaping disparities at the intersection of gender identity and race\/ethnicity in a population-based sample of adolescents. Nicotine Tob Res. 2021;24(3):349\u201357. https:\/\/doi.org\/10.1093\/ntr\/ntab152.","journal-title":"Nicotine Tob Res"},{"issue":"4","key":"1047_CR65","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/15532739.2011.700873","volume":"13","author":"E Coleman","year":"2012","unstructured":"Coleman E, Bockting W, Botzer M, Cohen-Kettenis P, DeCuypere G, Feldman J, et al. Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7. Int J Transgenderism. 2012;13(4):165\u2013232. https:\/\/doi.org\/10.1080\/15532739.2011.700873.","journal-title":"Int J Transgenderism"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-022-01047-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11883-022-01047-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-022-01047-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T03:38:18Z","timestamp":1661225898000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11883-022-01047-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":65,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["1047"],"URL":"https:\/\/doi.org\/10.1007\/s11883-022-01047-1","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"value":"1523-3804","type":"print"},{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,29]]},"assertion":[{"value":"8 June 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Eugenia Gianos reports the following disclosures: moderator for Kaneka, research grant from AstraZeneca, and Faculty for CME activity for Med-IQ. The other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}